Heidelberg partners with pfenning Group on end-to-end pharma packaging, logistics solutions

By Public Technologies
  • Heidelberger Druckmaschinen entered a cooperation with Germany’s pfenning Group to deliver integrated solutions for pharmaceutical packaging production.
  • Partnership aims to link production, packaging, data management, and logistics into an end-to-end process for regulated pharma supply chains.
  • Focus includes higher efficiency, transparency, and compliance, addressing rising requirements for traceability, documentation, and serialization.
  • HEIDELBERG contributes printing, workflow integration, automation; pfenning adds pharma packaging capabilities, track-and-trace, serialisation, GDP/GMP-compliant logistics.
  • Announcement dated Sept. 30, 2026; deal supports HEIDELBERG’s push to expand beyond printing into full-system integration for packaging.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heidelberger Druckmaschinen AG published the original content used to generate this news brief on September 30, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.